Follow The Filings

CE Celanese

Celanese earnings company data as of 4:45 AM ET 11/1

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 2 Nov EPS 1.52 — —
Rev $2.62B — —

Insider trades

Open-market buys and sales by CE's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CE insider trades
  • $593K bought by 4 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Chuck Kyrish CFO
    Buy
    $105K 2,300 shares at $45.52 +8.6% to stake
    Traded Aug 14 Filed Aug 17
    ↗
  2. Ashley B Duffie SVP & Gc
    Buy
    $27K 600 shares at $45.60 +1.9% to stake
    Traded Aug 11 Filed Aug 13
    ↗
  3. Mark Christopher Murray SVP - Acetyls
    Buy
    $98K 2,153 shares at $45.52 +7.6% to stake
    Traded Aug 11 Filed Aug 12
    ↗
  4. Scott A Richardson CEO
    Buy
    $158K 3,800 shares at $41.59 +5.7% to stake
    Traded Dec 10, 2025 Filed Dec 12, 2025
    ↗
  5. Chuck Kyrish CFO
    Buy
    $205K 5,000 shares at $41.03 +85% to stake
    Traded Dec 9, 2025 Filed Dec 11, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 23 stock grants, 6 share withholdings for taxes, 3 sales back to the company, and 1 conversion.

SEC filings

Recent issuer filings from EDGAR, 19 shown.

Filed Form Detail Links
8-K/A 5.02 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
8-K 8.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G — Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02,9.01 Filing Doc
8-K 5.07,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc
DEFA14A Filing Doc

Source: SEC EDGAR submissions, updated 12 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.